Unknown

Dataset Information

0

Not All EGFR Exon 20 Insertions Are Created Equal.

ABSTRACT:

SUBMITTER: Lin YT 

PROVIDER: S-EPMC8474363 | biostudies-literature | 2020 Sep

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Not All EGFR Exon 20 Insertions Are Created Equal.

Lin Yen-Ting YT   Shih Jin-Yuan JY  

JTO clinical and research reports 20200914 3

Similar Datasets

Unknown Amivantamab Plus Chemotherapy in Japanese Patients With EGFR Exon 20 Insertions NSCLC.
| S-EPMC12580869 | biostudies-literature
Unknown Response Heterogeneity of EGFR and HER2 Exon 20 Insertions to Covalent EGFR and HER2 Inhibitors.
| S-EPMC5596996 | biostudies-literature
Unknown Multinational proficiency tests for EGFR exon 20 insertions reveal that the assay design matters.
| S-EPMC11156884 | biostudies-literature
Unknown <i>EGFR</i> Testing Patterns and Detection of <i>EGFR</i> Exon 20 Insertions in the United States.
| S-EPMC8851244 | biostudies-literature
Unknown Clinical characteristics of advanced non-small cell lung cancer patients with EGFR exon 20 insertions.
| S-EPMC8455549 | biostudies-literature
Unknown Antitumor Activity of Osimertinib, an Irreversible Mutant-Selective EGFR Tyrosine Kinase Inhibitor, in NSCLC Harboring EGFR Exon 20 Insertions.
| S-EPMC5932243 | biostudies-literature
Unknown Amivantamab and Mobocertinib in Exon 20 insertions EGFR Mutant Lung Cancer, Challenge To The Current Guidelines.
| S-EPMC9256830 | biostudies-literature
Unknown Spotlight on Amivantamab (JNJ-61186372) for EGFR Exon 20 Insertions Positive Non-Small Cell Lung Cancer.
| S-EPMC8648093 | biostudies-literature
Unknown Variability of EGFR exon 20 insertions in 24 468 Chinese lung cancer patients and their divergent responses to EGFR inhibitors.
| S-EPMC7400778 | biostudies-literature
Unknown Diverse EGFR Exon 20 Insertions and Co-Occurring Molecular Alterations Identified by Comprehensive Genomic Profiling of NSCLC.
| S-EPMC6764748 | biostudies-literature